Riskpilot← Back to searchSign inGet full accessPREFORMA AS
ASActiveOrg 920697569Lille Starefossveien 32, 5019 BergenResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20180 employees
Revenue 2024
NOK 558K
+5% vs 2023
EBITDA margin
53.9%
+27% vs 2023
Equity ratio
43.2%
Financial strength
Net profit 2024
NOK -89K
+78% vs 2023
| Revenue | NOK 558K | +5% |
| EBITDA | NOK 301K | +27% |
| Net profit | NOK -89K | +78% |
| Total assets | NOK 1,9M | -6% |
| Equity | NOK 827K | -10% |
| Employees | 0 | — |
Legal name
PREFORMA AS
Org number
920697569
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
9. april 2018
Share capital
NOK 34 550
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Forskning og utvikling av hjelpemidler og verktøy innen helse. Selskapets virksomhet kan også inkludere drift som naturlig faller sammen med dette, herunder kantinedrift, å delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer.
Address
Lille Starefossveien 32, 5019 Bergen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 40 | 700 | 602 | 2 486 | 530 | 558 |
| Staff expenses | −0 | −0 | −0 | −1 | −0 | −0 | −0 |
| EBITDA | −7 | −12 | 242 | 227 | 1 102 | 237 | 301 |
| Depreciation & amort. | −0 | −0 | −0 | −207 | −355 | −641 | −391 |
| EBIT | −7 | −12 | 242 | 20 | 747 | −403 | −90 |
| Net financials | 0 | 0 | −1 | −0 | −1 | −1 | 2 |
| Profit before tax | −7 | −12 | 241 | 20 | 747 | −405 | −89 |
| Tax | −0 | −0 | 49 | 4 | 167 | −9 | −0 |
| Net profit | −7 | −12 | 192 | 15 | 580 | −396 | −89 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 23 | 844 | 1 048 | 1 276 | 3 385 | 2 025 | 1 914 |
| Equity | 23 | 11 | 630 | 901 | 1 480 | 916 | 827 |
| Long-term debt | 0 | 0 | 0 | 0 | 56 | 0 | 0 |
| Short-term debt | 0 | 834 | 418 | 375 | 1 848 | 1 110 | 1 087 |
| Total debt | 0 | 834 | 418 | 375 | 1 904 | 1 110 | 1 087 |
EBITDA margin
53.9%
This company
15.8%
Market median
+241% vs market
20182024
Equity ratio
43.2%
This company
38.2%
Market median
+13% vs market
20182024
Return on equity
-10.7%
This company
18.4%
Market median
-158% vs market
20182024
Net profit margin
-15.9%
This company
8.1%
Market median
-296% vs market
20182024
Asset turnover
0.29×
This company
1.12×
Market median
-74% vs market
20182024
Debt / equity
1.31×
This company
0.62×
Market median
-111% vs market
20182024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-02-07 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MT Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Raeder As | Company | 67.1% | 67.1% | 2024 |
Varsi Invest As | Company | 14.5% | 14.5% | 2024 |
Future State As | Company | 5.8% | 5.8% | 2024 |
Mabu Invest As | Company | 4.9% | 4.9% | 2024 |
Gynekolog Engelsen As | Company | 1.9% | 1.9% | 2024 |
| Individual | 1.9% | 1.9% | 2024 | |
Yngvild Skåtun Hannestad As | Company | 1.9% | 1.9% | 2024 |
| Individual | 1.0% | 1.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Raeder As
PREFORMA AS Board members of PREFORMA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Therese Barøy Ræder | Chief Executive Officer | 0 companies |
| Brita Gunilla Sandven | Board of Directors | 0 companies |
| Simon Sakkestad | Chairman | 0 companies |
| Rikke Knudsen | Board of Directors | 0 companies |
| Christoph Trattner | Board of Directors | 0 companies |
| Hallgeir Skøien Varsi | Board of Directors | 0 companies |